Welcome to HelioWave’s Investor Hub—a dedicated space designed to keep you informed, connected, and empowered. Here, you’ll find essential resources, fundraising details, and opportunities to stay engaged with HelioWave’s journey toward groundbreaking compliance testing.
At HelioWave, we’re proud to partner with forward-thinking investors who share our vision of creating impactful innovations.
HelioWave is backed by funding from DARPA, NIH, and USDA and support from BARDA BlueKnight and The Jlabs Incubator. These resources fuel our mission to advance product and consumer safety testing with state-of-the-art compliance techniques.
To date, we’ve raised $2.3 million
Funding includes:
DARPA SBIR (Phase I/II) HelioSAFE:
A Platform for the Fast, Label-Free, Automated Evaluation of Sterility
Contract: HR001121C0178, HR001122C0146
NIH SBIR (Phase I) HelioQUANT:
A Platform for Fast, Label-Free, Automated Evaluation of Bioburden
Contract: 1R43AI167567-01A1
USDA SBIR (Phase I) HelioCLEAN:
Miniaturized system for rapid monitoring of food borne pathogens
Contract: USDA-2025-00518
Currently in: Seed stage funding
Status: Open
Below, you’ll find all the resources you need to stay informed and confident in your partnership with HelioWave.